What can be concluded from the ERSPC and PLCO trial data?
Author:
Publisher
Elsevier BV
Subject
Urology,Oncology
Reference9 articles.
1. Screening and prostate-cancer mortality in a randomized European study;Schröder;N Engl J Med,2009
2. Mortality results from a randomized prostate-cancer screening trial;Andriole;N Engl J Med,2009
3. Prostate biopsy following a positive screen in the prostate, lung, colorectal and ovarian cancer screening trail;Pinsky;J Urol,2005
4. The changing face of prostate cancer;Cooperberg;J Clin Oncol,2005
5. Bicalutamide (150 mg) vs. placebo as immediate therapy alone or as adjuvant to therapy with curative intent for early nonmetastatic prostate cancer: 5.3-year median follow-up from the Scandinavian Prostate Cancer Group Study Number 6;Iversen;J Urol,2004
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Serum procalcitonin levels in prostate cancer: A new biomarker?;Urologia Journal;2018-03-23
2. The efficacy of prostate-specific antigen screening: Impact of key components in the ERSPC and PLCO trials;Cancer;2017-12-06
3. Urologic Oncology;Primer of Geriatric Urology;2016
4. Clinicopathologic features and determinants of Gleason score of prostate cancer in Ghanaian men;Urologic Oncology: Seminars and Original Investigations;2013-04
5. Análogos de la hormona liberadora de gonadotropinas en cáncer de próstata: ¿podemos considerarlos en realidad equivalentes?;Actas Urológicas Españolas;2013-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3